CG team performs rare angioplasty after pvt hosp fails
Raipur: Cardiologists and their team at the
Advanced Cardiac Institute
(ACI), located at Pt Jawaharlal Nehru Memorial Medical College and Dr Bhimrao Ambedkar Memorial Hospital, achieved a milestone at the national level.
They successfully performed angioplasty using
Excimer Laser Coronary Angioplasty
(ELCA) on a 70-year-old patient after a private hospital procedure failed, said the hospital spokesperson.
For the first time, a live demonstration of this procedure was witnessed by cardiologists from Jabalpur and other parts of the country. The virtual live workshop once again earned Chhattisgarh recognition at the national level in the healthcare sector.
The workshop was conducted under the leadership of Dr Smit Srivastava, head of the cardiology department.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
2025 Top Trending local enterprise accounting software [Click Here]
Esseps
Learn More
Undo
Excimer Laser Coronary Angioplasty (ELCA) is a specialised type of angioplasty that uses a laser to remove blockages (plaque, thrombus) from the coronary arteries. It is used in cases where traditional balloon angioplasty or stenting is insufficient. Dr Smit Srivastava stated that a 73-year-old patient had a blockage in the right coronary artery.
A private hospital attempted angioplasty, but the procedure was unsuccessful. Considering the patient's condition, doctors suggested Excimer Laser Coronary Angioplasty (ELCA) to break down the calcium and perform angioplasty. Dr Smit said that the Cardiological Society of India's conference was held in Jabalpur. At their request, the team contributed to the workshop's success by providing a live demonstration, which received appreciation.
Raipur: Cardiologists and their team at the Advanced Cardiac Institute (ACI), located at Pt Jawaharlal Nehru Memorial Medical College and Dr Bhimrao Ambedkar Memorial Hospital, achieved a milestone at the national level.
They successfully performed angioplasty using Excimer Laser Coronary Angioplasty (ELCA) on a 70-year-old patient after a private hospital procedure failed, said the hospital spokesperson.
For the first time, a live demonstration of this procedure was witnessed by cardiologists from Jabalpur and other parts of the country. The virtual live workshop once again earned Chhattisgarh recognition at the national level in the healthcare sector.
The workshop was conducted under the leadership of Dr Smit Srivastava, head of the cardiology department.
Excimer Laser Coronary Angioplasty (ELCA) is a specialised type of angioplasty that uses a laser to remove blockages (plaque, thrombus) from the coronary arteries. It is used in cases where traditional balloon angioplasty or stenting is insufficient. Dr Smit Srivastava stated that a 73-year-old patient had a blockage in the right coronary artery.
A private hospital attempted angioplasty, but the procedure was unsuccessful. Considering the patient's condition, doctors suggested Excimer Laser Coronary Angioplasty (ELCA) to break down the calcium and perform angioplasty. Dr Smit said that the Cardiological Society of India's conference was held in Jabalpur. At their request, the team contributed to the workshop's success by providing a live demonstration, which received appreciation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Looking for the perfect perfume? Well, it's synthesized on your skin
Dr Abdul Ghafur, an infectious disease expert is swabbing skin and using genetic sequencing to analyse epidermal bacteria -- not for diagnosing diseases but to recommend personalized perfumes based on an individual's unique skin microbiome. "Understanding the skin's microbiome is revolutionising how we approach the choice of perfumes. It moves beyond simply picking a scent to a personalised, scientifically-backed approach that considers your unique body chemistry," Dr Ghafur said. In May, Dr Ghafur, who works at Apollo Hospitals in Teynampet, started Fragragenomics Biotech (P) Ltd to help people make the right perfume choices. He launched the company owing to his interest in perfumes, his knowledge of microbiomes, and his frustration with some of the world's most famous fragrances that failed on his body. "It was during my work on microbiomes during the pandemic that I found the reasons," he said. The skin is home to trillions of microorganisms, including bacteria and fungi, that comprise your skin microbiome. "When we think of microorganisms, we think they are all bad. That's not true. At least 99.99% of the bugs are either neutral or good for humans. Less than 0.001% cause diseases," he said. No two people have the same composition of skin microbes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Preparado para todo con hasta 10 años de garantía Nissan X-Trail Obtén ofertas Undo These microbes interact with compounds in the sweat, oils, and dead skin cells, metabolising them into volatile organic compounds. "These compounds, not sweat itself, create a unique, natural body odour. This scent fingerprint is influenced by genetics, diet, lifestyle, environment, and hormones. So everyone has a unique body odour," he said. Distilling the right perfume depends a lot on this. While sight or sound might dominate our conscious experience, scent often triggers far more vivid recollections. The olfactory pathways in the brain are fascinating neural routes that allow us to perceive and interpret smells. Unlike sight or hearing, the sense of smell takes a direct path to the brain, often bypassing the thalamus, which is a relay station for most other sensory information. Dr Ghafur's passion drove him to visit numerous perfumeries both in India and abroad. "Many perfumers were happy to discuss science," he said. The global perfume market was valued at about $50-55 billion in 2024. It's projected to touch an estimated $77-88 billion by 2032-2033, with a CAGR of about 5.3% to 5.9%. So, any scientific advancement that can attract more customers or bring in new ones is generally well-received. Customers perceive perfumes as much more than just a pleasant smell. They are seen as complex compositions that can influence emotions, shape perceptions, trigger memories, and serve as a subtle yet powerful extension of one's identity. "I don't feel shy to ask my patients or colleagues about the perfumes they use. Or I simply tell them the flavours in their perfume. Some think I am entering their personal space, but once I discuss science, they seem interested," he said. A common complaint is that a perfume didn't last as long as expected. Over the past few months, he has been testing and discussing what kind of bacteria produces a strong body odour and the kinds of scent profiles that will suit them. For instance, bacteria such as Corynebacterium, Staphylococcus epidermidis, and Propionibacterium acnes feed on the proteins, fats, and oils in the sweat, especially in armpits, groin, and feet. They break these down into smaller, smelly molecules. When the "good" or neutral bacteria such as Micrococcus or Lactobacillus are thriving, they can help maintain a healthy skin environment, possibly by producing acids that inhibit odour-causing bacteria, or simply by not producing strong offensive smells themselves. He offers his patients tips on the top notes – the flavours that last for up to ten minutes, the middle notes, the ones that last for about four hours, and the base notes that will last for hours to days. The skin microbiome metagenomic test, of course, is not for everyone. "We can't tell everyone to go for testing. But we want to make them aware of how some volatile organic compounds work. The result is no one buys perfume after smelling a sheet of paper or during the two-hour layover at an airport," he said. Dr Ghafur has made a presentation about skin microbiomes in people with diabetes – how a systemic environment can lead to a less healthy, less diverse skin microbiome, contributing to specific body odours. "Many doctors were interested. They called back too," he said.
Time of India
an hour ago
- Time of India
Restore medical treatment of ex-serviceman's dependent under ECHS regardless of PWD Act listing: AFT to MoD
Chandigarh: The ministry of defence (MoD) cannot deny medical treatment under the Ex-Servicemen Contributory Health Scheme (ECHS) to dependents of a member merely because their ailment is not listed as a disability under the Rights of Persons with Disabilities (PWD) Act, 2016, according to an Armed Forces Tribunal (AFT) ruling. The tribunal also clarified that the authorities are supposed to consider practical as well as compassionate aspects when cancelling or withdrawing any policy or letter and "are under obligation to see that no one is harmed". A division bench comprising Justice Anil Kumar, judicial member, and Vice Admiral Atul Kumar Jain, administration member of AFT Lucknow, passed these orders while allowing an application filed by Sheela Devi, widow of Havildar Ganga Sahay. She sought directions to issue an order to the MoD to continue her son's treatment after a kidney transplant, which was stopped after he turned 25 years, as per a policy letter dated Dec 5, 2017, issued by the ministry of defence (DoESW). The applicant's husband joined the Indian Army in 1974, was discharged from service in 1996, and died in 2003. Thereafter, the applicant was issued an ECHS card, which included all her family members. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Keep Your Home Efficient with This Plug-In elecTrick - Save upto 80% on Power Bill Learn More Undo Her son, Mohit Kumar, was admitted to the Command Hospital, Lucknow, in Aug 2021 and was diagnosed with 'Advanced Renal Dysfunction with Small Echogenic Kidney' and was advised to undergo a kidney transplant. The applicant donated a kidney to her son, which was transplanted on June 14, 2023, and since then, her son has been under treatment through ECHS. However, she was informed by the authorities that her son does not fall under the PWD Act, 2016, and therefore, he is not eligible for further treatment through ECHS beyond the age of 25. Aggrieved by the authorities' decision, she approached the AFT Lucknow. She contended that after her husband's death, she is in a financial crisis as she does not have any other source of income except a meagre family pension. The counsel for the applicant further submitted that her son's disability (chronic kidney disease) being a renal transplant case was permanent in nature and assessed at 80-90%. He also submitted that the treatment could not be stopped on the grounds of the disease not being included in the list of disabilities under the PWD Act, 2016, as he has been under treatment for chronic kidney disease since Aug 2021. Counsel representing the MoD reiterated that the treatment of the applicant's son was stopped as per rules because the kidney disease is not included in the list of 21 disabilities under the PWD Act, 2016, and her son has crossed the permissible age of 25 years. After hearing all the parties, the AFT held that the authorities acted in a very casual manner without considering the fact that he is suffering from a serious kidney ailment that threatens his life. In its detailed order released last week, the AFT further directed the MoD to restore or restart the treatment, considering it as a special case, and to reimburse the expenses incurred by the applicant in the treatment of her son from the date of stoppage of the treatment until its actual restoration.
Time of India
an hour ago
- Time of India
U-Win vaccine portal a game changer for pregnant women, kids in Mysuru district
Mysuru: The launch of the U-Win online vaccine management portal by state health department has significantly improved access to vaccination and medicines for pregnant women and newborns in Mysuru district. Since its introduction in April 2024, over 16,000 pregnant women and 1.3 lakh children have benefited. The platform ensures a permanent digital record of vaccines and medicines administered to pregnant women, including children, streamlining immunisation healthcare services. It tracks each pregnant woman, newborn, child, and adolescent in real time, facilitating vaccination planning, beneficiary registration, and digital updates on vaccination status at the last mile of service delivery. All the 25 shots of vaccination from newborn to adolescent stage of the children, and two shots of vaccine administered for pregnant women are registered digitally under this platform. This platform is also designed to link with Ayushman Bharath Digital Mission. U-Win also integrates with other Healthcare Professional Registry (HPR), Healthcare Facility Registry (HFR), and ABHA systems, ensuring interoperability with existing healthcare management systems of govt. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 오스템 임플란트 받아가세요 임플란터 더 알아보기 Undo All pregnant women can self-register on the U-Win vaccination portal. If registered on CoWIN, they need to use the same mobile number to access U-Win. Registration can also be done through walk-in/on-site mode at the nearest primary health centre. Among the 16,004 pregnant women and 1.3 lakh children who benefited under the portal after its launch in the district, district reproductive and children health officer Dr Mohammed Siraj said that children up to the age of six years and all pregnant mothers are registered on U-Win using govt ID like Aadhar and their mobile phone numbers. Upon registration, records of all 25 shots given to children and the two given to pregnant mothers are uploaded to this portal. Digital vaccine certificates There is also a provision for mothers to access digital vaccine certificates, which can be downloaded by parents using their registered mobile numbers. This allows one to get vaccinated anywhere in the country through this digital solution, he said. Speaking to TOI, district health officer Dr PC Kumaraswamy said that the launch of these digital solutions not only made the vaccination administration drive for both children and pregnant women to save their precious lives, but also made it easy for health professionals to achieve a cent percent target for the universal immunisation drive. |
